Watch this MedPage Today interview with AACE President Scott D. Isaacs, MD, FACP, FACE, as he recaps key takeaways from the recent AACE Annual Meeting. He discusses the meeting’s theme of endocrine innovation and obesity breakthroughs, including a keynote by Dr. Daniel Drucker on the evolution of GLP-1 therapies. Dr. Isaacs also shares insights from a symposium on metabolic dysfunction-associated steatotic liver disease (MASLD) and emphasizes the importance of screening high-risk patients for metabolic liver disease.